Zepbound Savings Card: How to Get $25/Month (2026 Guide)

What is the Zepbound savings card?

Zepbound is tirzepatide, approved for chronic weight management. The Zepbound savings card is a copay reduction program Lilly applies at the pharmacy counter after your insurance has already processed the claim. It is not a coupon, not insurance, and not a discount card you can use on its own. Your plan pays first, then the card knocks down whatever copay is left, down to a floor of $25 for a 1, 2, or 3-month prescription.

The word "if" is doing heavy lifting. Every headline figure on this page belongs to one tier: commercially insured patients whose plan actually covers Zepbound. If your plan excludes weight-management drugs, there is no copay for the card to reduce, and you land on a different tier covered further down. Lilly's separate self-pay channel prices Zepbound by dose rather than by insurance status, roughly $299 to $449 per month depending on which strength you are on, with both pens and vials sold that way. That route is covered in depth in the LillyDirect Zepbound guide, and the full price stack across every channel sits in the Zepbound cost guide. This article stays on the savings card.

It is not the same as the Mounjaro card

Zepbound and Mounjaro are the same molecule sold under two labels for two indications: Zepbound for weight management, Mounjaro for type 2 diabetes. Lilly runs a separate savings program for each, with separate terms and separate annual caps. Each card is issued against its own brand, so the Mounjaro card is not a substitute for the Zepbound one at the counter. The side-by-side further down lays out both programs.

Zepbound savings card eligibility: who qualifies for the $25 tier?

Eligibility comes down to one question, then a short exclusion list. The diagram below maps the branches.

Which Zepbound access path applies to you, based on your insurance status.

Commercially insured with Zepbound coverage

This is the $25 tier. You need active commercial insurance (an employer plan or similar private coverage) that lists Zepbound on its formulary for weight management, plus a valid prescription. Coverage is the gate, not the card. Some commercial plans carve out anti-obesity medications, and in that case you are commercially insured but still outside this tier. The next branch is where you land instead.

Commercially insured without Zepbound coverage

This branch gets missed a lot. Lilly's terms carry a second tier for patients who hold commercial drug insurance that does not provide coverage for Zepbound. Those patients pay as low as $299 for a 1-month fill of the 2.5 mg single-patient-use KwikPen, with higher strengths priced further up the same by-dose ladder, capped at 11 fills per calendar year. It is not $25, and it is a different product presentation than the covered tier, but it is still the savings card doing the work rather than a separate program.

Government insurance exclusions

Lilly's terms name these plans as excluded from the savings card: Medicare, Medicaid, Medicare Part D, Medicare Advantage, Medigap, the Department of Defense, the VA, and TRICARE, along with state prescription drug assistance programs. The terms state this as a flat condition of eligibility, so it is not something Lilly or your pharmacist can waive. If you are on any of these, skip to the Medicare GLP-1 Bridge section below.

FEHB, ACA marketplace, and state employee plans

These three sit in a gray zone, because Lilly's published terms do not name them either way. What the terms do say is that government-funded healthcare programs are excluded as a category. Reading that against how each plan type is funded:

• FEHB (Federal Employees Health Benefits): federal-employee coverage, so it may sit inside the broad government-funded exclusion language even though it is not separately named. Treat the card as very unlikely to apply and confirm with Lilly directly before counting on it.
• ACA marketplace plans: privately underwritten commercial insurance, so they are generally treated like any other commercial plan. Eligibility still depends on whether your specific plan covers Zepbound, and marketplace formularies vary a lot.
• State and municipal employee plans: usually employer-sponsored commercial coverage, which follows the commercial rule. A minority are state-government self-funded plans that would fall under the exclusion, so check your plan documents.

None of this is settled in writing by Lilly. If you are in one of these three categories, call the number on the savings program page and get an answer for your specific plan before you build a budget around $25.

How much does the Zepbound savings card actually cover?

"As little as $25" is the floor, not a promise. The card pays a limited amount toward your copay, and once those limits are spent, your plan's normal cost-sharing takes over. As of July 2026 the limits are:

• Up to $100 of savings on a 1-month fill.
• Up to $200 on a 2-month fill.
• Up to $300 on a 3-month fill.
• Up to $1,300 total per calendar year, across a maximum of 13 fills.

One definition matters before the math: Lilly counts a 1-month fill as 28 days, so 13 fills fit inside one calendar year. A patient whose plan leaves a $125 copay per fill gets $100 of help, pays $25, and consumes $100 of the annual allowance each time. That patient exhausts $1,300 on the thirteenth fill, which in practice means the card carries them through a full calendar year and no further. A patient on a high-deductible plan facing a $600 copay in January still only gets $100 of help, pays $500 out of pocket, and burns the same $100 of allowance. Same card, very different year.

Zepbound monthly cost by access route, against a list price of roughly $1,086 per month.

How to enroll in the Zepbound savings card step by step

Enrollment itself is the quick part. The slow part is everything around it.

1. Confirm your plan covers Zepbound. Call the pharmacy benefits number on the back of your insurance card and ask whether Zepbound is on the formulary for weight management and whether prior authorization is required. This one call tells you which tier you are in.
2. Get the prescription written for branded Zepbound. The card does not apply to compounded tirzepatide.
3. Activate the card at zepbound.lilly.com/savings. It is free, and you get a digital card immediately.
4. Clear prior authorization. Most plans require your prescriber to document the weight-management diagnosis. Until that clears, the claim is not payable and the card has nothing to reduce.
5. Present the card at the pharmacy when the prescription is dispensed. The pharmacist applies it after your insurance processes the claim, not instead of it.

Step four is a common stalling point. The card is a copay tool, not a coverage tool, and a pending or denied prior authorization looks identical at the counter to a broken card. If your prior authorization is denied, ask your prescriber to appeal with supporting documentation before assuming the savings program failed you.

Zepbound savings card not working? Five reasons and their fixes

The pharmacy system almost never explains a rejection in plain language. In practice it is one of these five.

One more that catches people: the terms require that you not be enrolled in any government-funded program. If one is on your pharmacy profile, ask the pharmacist to confirm which plans are active on your file.

On The Pen, a GLP-1 news channel, walks through the 2026 Zepbound savings card terms.

If the card does not apply to you, here are the alternatives

Three routes exist outside the savings card, and which one fits depends on your coverage rather than your preference.

• Lilly self-pay pricing. Roughly $299 to $449 per month, tiered by dose rather than by device, so both pens and vials follow the same ladder. Refilling within about 45 days holds your price at that rate. Full mechanics in the LillyDirect Zepbound guide.
• Discount cards such as GoodRx. These price against the roughly $1,086 list price rather than against Lilly's self-pay rate. Pull a live quote before assuming it competes.
• The Medicare GLP-1 Bridge, if you are on Part D. This is new and gets its own section next.

If you are weighing brands rather than routes, Mounjaro vs Zepbound covers which label applies to which diagnosis, and the tirzepatide hub collects the rest of the cluster.

New for 2026: the Medicare GLP-1 Bridge

Medicare patients have been shut out of manufacturer copay cards for years, and that has not changed. What changed on July 1, 2026 is that a separate path opened. Under the Medicare GLP-1 Bridge, eligible Part D enrollees who meet the program's clinical criteria and obtain prior authorization can get the Zepbound KwikPen for $50 per month. The program runs through December 31, 2027.

If you are on Part D, this is the path to ask your prescriber about, not the savings card. The card remains unavailable to you regardless of the Bridge.

Zepbound savings card vs Mounjaro savings card

Same molecule, two programs. The copay floor matches, the annual ceilings do not, and Zepbound's is the smaller of the two.

Both cards stop at 13 fills a year. Zepbound's absorbs up to $100 per fill against Mounjaro's $150, so the same copay leaves a Zepbound patient paying more out of pocket across the year, not running out earlier. The Mounjaro savings card guide covers that program's own terms in detail. If you are on semaglutide instead, the Wegovy savings card guide is the equivalent article.